« FDA Takes Action to Stop Marketing of Unapproved Hydrocodone Products | Main | FDA Approvals - FDA to extend review of Biogen's Tysabri (BizJournals) Cambridge-based Biogen »

FDA Acts to Ensure Thyroid Drugs Don t Lose Potency Before


FDA Acts to Ensure Thyroid Drugs Don t Lose Potency Before Expiration Date
The U.S. Food and Drug Administration is tightening the potency specifications for levothyroxine sodium, used to treat underactive thyroid glands and other thyroid conditions, to ensure the drug retains its potency over its entire shelf life.
 

©2006 FDA-News.com. All rights reserved.